The Patent Finder

Arius Research Inc.

Also on record
Records under this name other than patents Arius Research Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Arius Research Inc.

PatentTitleStatus Expires Confidence
US 7,149,792Device registration mechanism
Formerly held
Term ended
Term ended Nov 24, 2021 · From the USPTO record
Term endedTerm ended Nov 24, 2021From the USPTO record
US 7,361,342Cancerous Disease Modifying Antibodies
Formerly held
Term ended
Ended no later than Feb 10, 2021 · Low confidence
Term endedEnded no later than Feb 10, 2021Low confidence
US 7,442,776Cancerous Disease Modifying Antibodies
Formerly held
Lapsed on the fee record
Ended Oct 28, 2020 · Medium confidence
Lapsed on the fee recordEnded Oct 28, 2020Medium confidence
US 8,277,803Cancerous Disease Modifying Antibodies
Formerly held
Lapsed on the fee record
Ended Oct 2, 2020 · High confidence
Lapsed on the fee recordEnded Oct 2, 2020High confidence
US 7,419,792Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody
Formerly held
Term ended
Term ended Jul 9, 2020 · From the USPTO record
Term endedTerm ended Jul 9, 2020From the USPTO record
US 7,393,531Cytotoxicity Mediation of Cells Evidencing Surface Expression of MCSP
Formerly held
Lapsed on the fee record
Ended Jul 1, 2020 · Low confidence
Lapsed on the fee recordEnded Jul 1, 2020Low confidence
US 8,129,502Cancerous Disease Modifying Antibodies
Lapsed on the fee record
Ended Mar 6, 2020 · High confidence
Lapsed on the fee recordEnded Mar 6, 2020High confidence
US 8,071,072Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
Term ended
Term ended Nov 7, 2019 · Medium confidence
Term endedTerm ended Nov 7, 2019Medium confidence
US 8,048,416Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
Lapsed on the fee record
Ended Nov 1, 2019 · Medium confidence
Lapsed on the fee recordEnded Nov 1, 2019Medium confidence
US 6,180,357Individualized patient-specific anti-cancer antibodies
Formerly held
Term ended
Term ended Oct 8, 2019 · From the USPTO record
Term endedTerm ended Oct 8, 2019From the USPTO record
10 of 47 patents shown.
Pro members see all 47.
Pro members: see all 47 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited